D. Helou
发表
M. Pallardy,
S. Chollet-Martin,
S. Kerdine-Römer,
2019,
The Journal of Immunology.
M. Pallardy,
S. Chollet-Martin,
Stefan F Martin,
2019,
Front. Immunol..
F. Gilliland,
O. Akbari,
V. Rehan,
2019,
Front. Immunol..
O. Akbari,
Jacob D. Painter,
E. Howard,
2021,
The Journal of allergy and clinical immunology.
O. Akbari,
J. Emamaullee,
Jacob D. Painter,
2022,
Nature Communications.
O. Akbari,
Jacob D. Painter,
P. Soroosh,
2020,
The Journal of allergy and clinical immunology.
O. Akbari,
P. Soroosh,
Homayon Banie,
2019,
Cell reports.
H. Allayee,
O. Akbari,
Jacob D. Painter,
2021,
Mucosal Immunology.
A. Sharpe,
O. Akbari,
Jacob D. Painter,
2022,
Nature Communications.
A. Sharpe,
O. Akbari,
Jacob D. Painter,
2021,
Frontiers in Immunology.
PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity
A. Sharpe,
O. Akbari,
Jacob D. Painter,
2020,
Nature Communications.
O. Akbari,
Jacob D. Painter,
E. Howard,
2020,
Frontiers in Immunology.
S. Cojean,
P. Loiseau,
D. Betbeder,
2021,
PLoS neglected tropical diseases.
Y. Loh,
O. Akbari,
J. Emamaullee,
2021,
Frontiers in Immunology.
Y. Loh,
O. Akbari,
J. Emamaullee,
2021
.
Y. Loh,
O. Akbari,
J. Emamaullee,
2021,
bioRxiv.
O. Akbari,
Jacob D. Painter,
P. Soroosh,
2020,
Nature Communications.
Y. Loh,
O. Akbari,
Jacob D. Painter,
2021,
Nature Communications.
R. Bataller,
J. Pais de Barros,
É. Drumez,
2020,
Journal of hepatology.
M. Pallardy,
S. Chollet-Martin,
L. de Chaisemartin,
2019,
PloS one.
D. Helou,
Deepak Pokhreal,
Bruno Crestani,
2023,
Cells.
O. Akbari,
D. Helou,
Benjamin P. Hurrell,
2023,
Mucosal Immunology.
A. Sharpe,
O. Akbari,
Jacob D. Painter,
2022,
The Journal of allergy and clinical immunology.
O. Akbari,
Jacob D. Painter,
E. Howard,
2021,
The Journal of allergy and clinical immunology.
D. Helou,
Benjamin P. Hurrell,
Christine Quach,
2024,
Science Translational Medicine.
J. Ou,
V. Rehan,
P. Soroosh,
2023,
Cell reports.